CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: tenofovir (anhydrous)
Accession: CHEBI:63625
browse the term
Definition: A member of the class of phosphonic acids that is methylphosphonic acid in which one of the methyl hydrogens is replaced by a [(2R)-1-(6-amino-9H-purin-9-yl)propan-2-yl]oxy group. An inhibitor of HIV-1 reverse transcriptase, the bis(isopropyloxycarbonyloxymethyl) ester (disoproxil ester) prodrug is used as the fumaric acid salt in combination therapy for the treatment of HIV infection.
Synonyms: exact_synonym: ({[(2R)-1-(6-amino-9H-purin-9-yl)propan-2-yl]oxy}methyl)phosphonic acid
related_synonym: (R)-PMPA; Formula=C9H14N5O4P; InChI=1S/C9H14N5O4P/c1-6(18-5-19(15,16)17)2-14-4-13-7-8(10)11-3-12-9(7)14/h3-4,6H,2,5H2,1H3,(H2,10,11,12)(H2,15,16,17)/t6-/m1/s1; InChIKey=SGOIRFVFHAKUTI-ZCFIWIBFSA-N; SMILES=C[C@H](Cn1cnc2c(N)ncnc12)OCP(O)(O)=O; anh. tenofovir; tenofovir
xref: CAS:147127-20-6; DrugBank:DB00300; HMDB:HMDB0014445; KEGG:D06074; LINCS:LSM-5340; PMID:11777298; PMID:25017682; PMID:28166217; PMID:28503983; Reaxys:7415378; Wikipedia:Tenofovir
cyclic_relationship: is_conjugate_acid_of CHEBI:134504
G
Abcb4
ATP binding cassette subfamily B member 4
decreases activity
ISO
Tenofovir results in decreased activity of ABCB4 protein
CTD
PMID:28437613
NCBI chr 4:22,133,984...22,192,687
Ensembl chr 4:22,133,521...22,425,515
G
Acacb
acetyl-CoA carboxylase beta
affects expression
ISO
Tenofovir affects the expression of ACACB mRNA
CTD
PMID:20032539
NCBI chr12:48,127,149...48,238,969
Ensembl chr12:48,127,149...48,238,887
G
Bnip3l
BCL2 interacting protein 3 like
increases expression
ISO
Tenofovir results in increased expression of BNIP3L protein
CTD
PMID:23640862
NCBI chr15:43,643,897...43,667,123
Ensembl chr15:43,643,897...43,667,029
G
Ccl20
C-C motif chemokine ligand 20
increases expression multiple interactions
ISO
Tenofovir results in increased expression of CCL20 mRNA Tenofovir results in increased expression of and results in increased secretion of CCL20 protein
CTD
PMID:24205323
NCBI chr 9:88,918,359...88,921,017
Ensembl chr 9:88,918,433...88,921,001
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
multiple interactions increases expression
ISO
[Emtricitabine co-treated with Tenofovir] results in increased expression of CDKN1A protein Tenofovir results in increased expression of CDKN1A protein
CTD
PMID:31545371
NCBI chr20:6,348,422...6,358,864
Ensembl chr20:6,351,458...6,358,864
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
decreases activity
ISO
Tenofovir results in decreased activity of CYP2E1 protein
CTD
PMID:17162464
NCBI chr 1:213,511,892...213,522,195
Ensembl chr 1:213,511,874...213,535,542
G
Edn1
endothelin 1
increases secretion multiple interactions
ISO
Tenofovir results in increased secretion of EDN1 protein coenzyme Q10 inhibits the reaction [Tenofovir results in increased secretion of EDN1 protein]
CTD
PMID:23640862
NCBI chr17:22,136,814...22,143,745
Ensembl chr17:22,137,324...22,143,324
G
Eif2s1
eukaryotic translation initiation factor 2 subunit alpha
affects phosphorylation
ISO
Tenofovir affects the phosphorylation of EIF2S1 protein
CTD
PMID:27041070
NCBI chr 6:102,048,372...102,073,041
Ensembl chr 6:102,048,372...102,073,041
G
Havcr1
hepatitis A virus cellular receptor 1
increases secretion multiple interactions
ISO
Tenofovir results in increased secretion of HAVCR1 protein Tenofovir inhibits the reaction [cidofovir results in increased secretion of HAVCR1 protein]
CTD
PMID:29738843
NCBI chr10:31,813,819...31,860,934
Ensembl chr10:31,813,814...31,848,379
G
Hsd11b1
hydroxysteroid 11-beta dehydrogenase 1
affects expression
ISO
Tenofovir affects the expression of HSD11B1 mRNA
CTD
PMID:20032539
NCBI chr13:111,946,626...111,996,536
Ensembl chr13:111,926,442...111,972,603
G
Hspd1
heat shock protein family D (Hsp60) member 1
affects expression
ISO
Tenofovir affects the expression of HSPD1 protein
CTD
PMID:27041070
NCBI chr 9:61,680,529...61,691,202
Ensembl chr 9:61,680,530...61,690,956
G
Lipe
lipase E, hormone sensitive type
affects expression
ISO
Tenofovir affects the expression of LIPE mRNA
CTD
PMID:20032539
NCBI chr 1:82,248,031...82,266,727
Ensembl chr 1:82,248,046...82,266,727
G
Lonp1
lon peptidase 1, mitochondrial
affects expression
ISO
Tenofovir affects the expression of LONP1 protein
CTD
PMID:27041070
NCBI chr 9:10,428,853...10,441,180
Ensembl chr 9:10,428,853...10,441,177
G
Mapk8
mitogen-activated protein kinase 8
affects phosphorylation
ISO
Tenofovir affects the phosphorylation of MAPK8 protein
CTD
PMID:27041070
NCBI chr16:9,620,854...9,709,342
Ensembl chr16:9,625,177...9,709,347
G
Mt-co2
mitochondrially encoded cytochrome c oxidase II
multiple interactions
ISO
Tenofovir promotes the reaction [Didanosine results in decreased expression of COX2 mRNA]
CTD
PMID:16940060
NCBI chr MT:7,006...7,689
Ensembl chr MT:7,006...7,689
G
Nfkbia
NFKB inhibitor alpha
decreases expression
EXP
Tenofovir results in decreased expression of NFKBIA protein
CTD
PMID:27899301
NCBI chr 6:76,267,227...76,270,457
Ensembl chr 6:76,267,228...76,270,457
G
Nos2
nitric oxide synthase 2
increases expression
EXP
Tenofovir results in increased expression of NOS2 mRNA; Tenofovir results in increased expression of NOS2 protein
CTD
PMID:27899301
NCBI chr10:66,188,290...66,221,621
Ensembl chr10:66,189,786...66,313,190
G
Nos3
nitric oxide synthase 3
multiple interactions decreases phosphorylation
ISO
coenzyme Q10 inhibits the reaction [Tenofovir results in decreased phosphorylation of NOS3 protein]
CTD
PMID:23640862
NCBI chr 4:7,321,908...7,342,404
Ensembl chr 4:7,320,668...7,342,410
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
affects expression
ISO
Tenofovir affects the expression of NR3C1 mRNA
CTD
PMID:20032539
NCBI chr18:31,728,373...32,704,022
Ensembl chr18:31,728,373...31,749,647
G
Nt5e
5' nucleotidase, ecto
increases expression
ISO
Tenofovir results in increased expression of NT5E mRNA
CTD
PMID:24205323
NCBI chr 8:95,969,002...96,012,733
Ensembl chr 8:95,968,652...96,012,696
G
Nt5m
5',3'-nucleotidase, mitochondrial
decreases expression
ISO
Tenofovir results in decreased expression of NT5M mRNA
CTD
PMID:24205323
NCBI chr10:46,216,494...46,244,478
Ensembl chr10:46,216,884...46,243,077
G
Pparg
peroxisome proliferator-activated receptor gamma
affects expression
ISO
Tenofovir affects the expression of PPARG mRNA
CTD
PMID:20032539
NCBI chr 4:147,274,055...147,399,383
Ensembl chr 4:147,274,107...147,399,380
G
Prkn
parkin RBR E3 ubiquitin protein ligase
multiple interactions
ISO
[Emtricitabine co-treated with Tenofovir] results in decreased expression of PRKN protein
CTD
PMID:31545371
NCBI chr 1:48,880,015...50,069,998
G
Ptgs2
prostaglandin-endoperoxide synthase 2
increases expression
EXP
Tenofovir results in increased expression of PTGS2 mRNA; Tenofovir results in increased expression of PTGS2 protein
CTD
PMID:27899301
NCBI chr13:67,351,230...67,356,920
Ensembl chr13:67,351,087...67,359,335
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions affects localization increases expression
EXP
Melatonin inhibits the reaction [Tenofovir affects the localization of RELA protein]; Melatonin inhibits the reaction [Tenofovir results in increased expression of and results in increased activity of RELA protein]; Melatonin inhibits the reaction [Tenofovir results in increased expression of RELA mRNA]; Tenofovir results in increased expression of and results in increased activity of RELA protein
CTD
PMID:27899301
NCBI chr 1:220,992,770...221,003,249
Ensembl chr 1:220,992,770...221,003,249
G
Sirt3
sirtuin 3
increases expression
ISO
Tenofovir results in increased expression of SIRT3 protein
CTD
PMID:27041070
NCBI chr 1:213,613,502...213,636,061
Ensembl chr 1:213,613,513...213,635,546
G
Slc22a6
solute carrier family 22 member 6
increases response to substance increases import multiple interactions
ISO
SLC22A6 protein results in increased susceptibility to Tenofovir SLC22A6 protein results in increased import of Tenofovir Probenecid inhibits the reaction [SLC22A6 protein results in increased susceptibility to Tenofovir]; SLC22A6 protein results in increased uptake of and results in increased susceptibility to Tenofovir; Tenofovir inhibits the reaction [SLC22A6 protein results in increased uptake of p-Aminohippuric Acid]
CTD
PMID:23856525 PMID:25448811 PMID:29738843
NCBI chr 1:224,824,809...224,833,284
Ensembl chr 1:224,824,799...224,833,259
G
Slc22a8
solute carrier family 22 member 8
increases response to substance increases import
ISO
SLC22A8 protein results in increased susceptibility to Tenofovir SLC22A8 protein results in increased import of Tenofovir
CTD
PMID:25448811 PMID:29738843
NCBI chr 1:224,799,444...224,818,482
Ensembl chr 1:224,800,252...224,818,482
G
Tnf
tumor necrosis factor
decreases expression increases expression
ISO EXP
Tenofovir results in decreased expression of TNF mRNA Tenofovir results in increased expression of TNF mRNA; Tenofovir results in increased expression of TNF protein
CTD
PMID:24205323 PMID:27899301
NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000 Ensembl chr20:5,189,390...5,192,000
G
Tp53
tumor protein p53
multiple interactions increases expression
ISO
[Emtricitabine co-treated with Tenofovir] results in increased expression of TP53 protein Tenofovir results in increased expression of TP53 protein
CTD
PMID:31545371
NCBI chr10:56,186,299...56,198,449
Ensembl chr10:56,187,020...56,198,449
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all